| Application no. and date | 03726489.2 (espacenet) (Federated) (European Patent Register), 20030425 | | Patent/reg. no. and date | DK/EP 1503788, 20110629 | | Publication date | 20050209 | | Priority no. and date | US 375584 P, 20020425 | | EP pub. no. and date |
EP 1503788 20050209 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome,
Chuo-ku,
Osaka-shi, Osaka, JP | | Applicant ref. no. | 11117-9 | | Inventor | TRECO, Douglas, A., 87 Brentwood Road
Arlington, MA 02476, US,
LOVEDAY, Kenneth,
Brookline, MA, US,
BOROWSKI, Marianne, PO BOX 1047,
5 West Ledge Road
Glen, NH 03838-3156, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 38/43 (2006.01) , A61K 38/47 (2006.01) | | Title | Behandling af alpha-galactosidase A-deficiens | | Int. application no. | US2003013063 | | Int. publication no. | WO2003090695 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
